AUM Cardiovascular secured clearance from the FDA for its new non-invasive acoustic and ECG device.

The CADence device is designed to track pathological and physiological heart murmurs. It records sounds originating in the heart to determine patients’ cardiovascular health.

The device is now available in the United States, and AUM is currently seeking clearance to market the device for detection of coronary artery disease.